US Patent 11787825 Therapeutic compounds for HIV virus infection
Patent 11787825 was granted and assigned to Gilead Sciences on October, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11787825 Therapeutic compounds for HIV virus infection
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.